Abstract
Despite improved understanding of the pathophysiology of heart failure (HF) and availability of better medical therapies, HF continues to grow as a cause of morbidity and mortality in Australia and worldwide. Over the past decade, cardiac resynchronisation therapy (CRT), or biventricular pacing, has been embraced as a powerful weapon against this growing epidemic. However, much has changed in our understanding of dyssynchrony in HF, and this has led to a change in guidelines to ensure more appropriate selection of CRT candidates to improve the 'non-response' rate. More data have also emerged about the use of CRT in atrial fibrillation and in pacemaker-dependent patients. There has also been a growing focus on multimodality imaging to guide patient selection and lead positioning. Exciting new lead technologies are also emerging, with the potential to improve CRT outcomes further.
Original language | English |
---|---|
Pages (from-to) | 255-265 |
Number of pages | 11 |
Journal | Internal Medicine Journal |
Volume | 46 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2016 |
Externally published | Yes |
Keywords
- Biventricular pacing
- Cardiac resynchronisation therapy
- Dyssynchrony
- Heart failure